Resources from the same session
Phase III KEYNOTE-048 study of first-line pembrolizumab for recurrent/metastatic head and neck squamous cell carcinoma: Asia vs non-Asia subgroup analysis
Presenter: Nuttapong Ngamphaiboon
Session: Mixed Proffered paper session - Gastrointestinal tumours & Head and neck cancers
Resources:
Slides
Webcast
Development and validation of a risk model integrating plasma Epstein-Barr virus DNA (EBV DNA) level and TNM stage for stratification of nasopharyngeal cancer (NPC) to adjuvant therapy
Presenter: Edwin Hui
Session: Mixed Proffered paper session - Gastrointestinal tumours & Head and neck cancers
Resources:
Slides
Webcast
Randomised efficacy and safety results for atezolizumab (Atezo) + bevacizumab (Bev) in patients (pts) with previously untreated, unresectable hepatocellular carcinoma (HCC)
Presenter: Chih-Hung Hsu
Session: Mixed Proffered paper session - Gastrointestinal tumours & Head and neck cancers
Resources:
Slides
Webcast
Invited Discussant LBA7
Presenter: Su Pin Choo
Session: Mixed Proffered paper session - Gastrointestinal tumours & Head and neck cancers
Resources:
Slides
Webcast
Invited Discussant 286O
Presenter: Brigette Ma
Session: Mixed Proffered paper session - Gastrointestinal tumours & Head and neck cancers
Resources:
Slides
Webcast